Sympathetic dysfunction in heart failure (Q40905075)

24 September 2017

1 reference

title

Sympathetic dysfunction in heart failure (English)

1 reference

24 September 2017

Shimizu K

1

1 reference

24 September 2017

McGrath BP

series ordinal

2

1 reference

24 September 2017

publication date

1 April 1993

1 reference

Bailliere's clinical endocrinology and metabolism

24 September 2017

published in

1 reference

24 September 2017

volume

7

1 reference

24 September 2017

issue

2

1 reference

24 September 2017

page(s)

439-463

1 reference

Myocardial catecholamine and neuropeptide Y depletion in failing ventricles of patients with idiopathic dilated cardiomyopathy. Correlation with beta-adrenergic receptor downregulation

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Vasoconstrictor role for vasopressin in experimental heart failure in the rabbit

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Vasopressin and angiotensin II contribute equally to the increased afterload in rabbits with heart failure.

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

The role of endogenous dopamine in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Angiotensin accelerates catecholamine biosynthesis in sympathetically innervated tissues

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Differences in beta-adrenergic neuroeffector mechanisms in ischemic versus idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Dysfunction of the beta- and alpha-adrenergic systems in a model of congestive heart failure. The pacing-overdrive dog.

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Mechanisms governing the postural response and baroreceptor abnormalities in chronic congestive heart failure: effects of acute and long-term converting-enzyme inhibition

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Cyclosporine: a new immunosuppressive agent for organ transplantation

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

The contribution of the renin-angiotensin system to limb vasoregulation in patients with heart failure: observations during orthostasis and alpha-adrenergic blockade.

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Sympathetic activity and regional blood flow in heart failure

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Defective cardiac parasympathetic control in patients with heart disease

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Effect of beta-adrenergic blockade on myocardial function and energetics in congestive heart failure. Improvements in hemodynamic, contractile, and diastolic performance with bucindolol

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Secretory mechanism of immunoreactive endothelin in cultured bovine endothelial cells

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Blunted Renal Response to Atrial Natriuretic Peptide in Congestive Heart Failure Rats Is Reversed by the α2-Adrenergic Agonist Clonidine

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Selective impairment of baroreflex-mediated vasoconstrictor responses in patients with ventricular dysfunction.

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Digitalis and baroreceptor reflexes in man

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Relationship of exercise capacity to resting left ventricular performance and basal plasma norepinephrine levels in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD)

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Noradrenaline turnover and metabolism in myocardium following aortic constriction in rats

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Acute and short-term effects of clonidine in heart failure

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

SODIUM DIURESIS PRODUCED BY DOPAMINE IN PATIENTS WITH CONGESTIVE HEART FAILURE

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Regional blood flow response to orthostasis in patients with congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Impairment of autonomically mediated heart rate control in patients with cardiac dysfunction

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Relationship between plasma norepinephrine and sympathetic neural activity

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Impaired atrial receptor responses in dogs with heart failure due to tricuspid insufficiency and pulmonary artery stenosis

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Increased beta-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Alterations in the baroreceptor reflex in conscious dogs with heart failure

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Cardiac 3,4-dihydroxyphenylethylene glycol (DHPG) and catecholamine levels in a rat model of left ventricular failure.

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Digitalis-induced augmentation of cardiopulmonary baroreflex control of forearm vascular resistance.

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Evidence for increased sympatho-adrenomedullary activity in young subjects with borderline hypertension

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril).

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Circulatory autoregulation in chronic congestive heart failure: Responses to head-up tilt in 41 patients

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Use of plasma norepinephrine for evaluation of sympathetic neuronal function in man

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Hydrochlorothiazide-induced sympathetic hyperactivity in hypertensive patients

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Regional distribution of the cardiac output and renal responses to atrial natriuretic peptide infusion in rabbits with congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Cardiovascular responses to graded treadmill exercise during the development of doxorubicin induced heart failure in rabbits.

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Vasoconstriction in the renal vascular bed during exercise: studies in control and heart failure rabbits

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure.

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Effects of orthotopic heart transplantation on sympathetic control mechanisms in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Hyponatremia in congestive heart failure: implications for neurohumoral activation and responses to orthostasis

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Cardiovascular reflexes from cardiac sensory receptors

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Modification of arterial baroreflexes by captopril in essential hypertension

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

EFFECT OF DOPAMINE IN MAN: AUGMENTATION OF SODIUM EXCRETION, GLOMERULAR FILTRATION RATE, AND RENAL PLASMA FLOW

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Enalapril reduces the catecholamine response to exercise in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Shift in the baroreflex-renal noradrenaline spillover curve during the development of congestive heart failure in the rabbit

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Plasma endothelin in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Marked increase of plasma 3,4-dihydroxyphenylacetic acid in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Evidence of a Selective Increase in Cardiac Sympathetic Activity in Patients with Sustained Ventricular Arrhythmias

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Regulation of the Renal Circulation during Severe Exercise in Normal Dogs and Dogs with Experimental Heart Failure

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Plasma norepinephrine concentration and plasma dopamine-beta-hydroxylase activity in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Myocardial norepinephrine, epinephrine and dopamine concentrations after cardiac autotransplantation in dogs

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Cyclosporine causes sympathetically mediated elevations in arterial pressure in rats

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Effect of angiotensin-converting enzyme inhibition on renal norepinephrine spillover rate and baroreflex responses in conscious rabbits

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Abnormal neurohumoral response to nitroprusside infusion in congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Influence of captopril on the arterial baroreceptor reflex in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Inhibition of noradrenaline uptake by angiotensin

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Alpha-adrenoceptor influence on plasma levels of neuropeptide Y-like immunoreactivity and catecholamines during rest and sympathoadrenal activation in humans

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Renal interaction between sympathetic activity and ANP in rats with chronic ischaemic heart failure

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Heterogeneous myocardial catecholamine concentrations in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Reduction of cardiac tyrosine hydroxylase activity in experimental congestive heart failure. Its role in the depletion of cardiac norepinephrine stores

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Effects of long-term therapy with oral ibopamine on resting hemodynamics and exercise capacity in patients with heart failure: relationship to the generation of N-methyldopamine and to plasma norepinephrine levels

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Sustained hemodynamic improvement during long-term therapy with levodopa in heart failure: role of plasma catecholamines.

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Predicting survival for an individual with congestive heart failure using the plasma norepinephrine concentration

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Myocardial catecholamine content after heart transplantation.

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Effects of quinapril on exercise tolerance in patients with mild to moderate heart failure

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

The renin-angiotensin-aldosterone system, antidiuretic hormone and sympathetic nerve activity in an experimental model of congestive heart failure in the dog

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Cyclosporine-induced sympathetic activation and hypertension after heart transplantation

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Evidence for regional catecholamine uptake and storage sites in the transplanted human heart by positron emission tomography

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Epidemiology of congestive heart failure

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

A possible change in the rate-limiting step for cardiac norepinephrine synthesis in the cardiomyopathic Syrian hamster

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Increased dopamine in the failing hamster heart: Transvesicular transport of dopamine limits the rate of norepinephrine synthesis

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

The Effects of Captopril on the Renin—Angiotensin System and the Sympathetic Nervous System During Sodium Nitroprusside-Induced Hypotension in the Halothane-Anesthetized Rabbit

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Skeletal muscle metaboreceptor exercise responses are attenuated in heart failure

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Altered skeletal muscle metabolic response to exercise in chronic heart failure. Relation to skeletal muscle aerobic enzyme activity

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Beneficial effects of long-term beta-blockade in congestive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Correlates and prognostic implication of exercise capacity in chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Plasma norepinephrine in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Interactions of vasopressin with the area postrema in arterial baroreflex function in conscious rabbits

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Endogenous catecholamine levels in chronic heart failure. Relation to the severity of hemodynamic abnormalities.

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Platelet alpha2 adrenoreceptors in chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Ventricular beta-adrenoceptors in adriamycin-induced cardiomyopathy in the rabbit

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries. A new mechanism of vasospasm?

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Alterations in vasomotor tone in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

Imparied atrial receptor modulation or renal nerve activity in dogs with chronic volume overload

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80183-1

7 January 2021

10.1016/S0950-351X(05)80183-1

Identifiers

DOI

1 reference

24 September 2017

1 reference